A detailed history of Macroview Investment Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Macroview Investment Management LLC holds 119 shares of ARVN stock, worth $2,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Previous 119 -0.0%
Holding current value
$2,983
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$14.19 - $42.33 $3,008 - $8,973
-212 Reduced 64.05%
119 $4,000
Q3 2023

Oct 26, 2023

BUY
$19.64 - $28.21 $6,500 - $9,337
331 New
331 $6,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.33B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.